Effects of various doses of aspirin on platelet activity and endothelial function

Heart and Vessels

Volumn 26, Issue 3, 2011, Pages 267-273

  Furuno, Takashi ^a   Yamasaki, Fumiyasu ^a   Yokoyama, Takeshi ^a   Sato, Kyoko ^a   Sato, Takayuki ^a   Doi, Yoshinori ^a   Sugiura, Tetsuro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Aspirin dose; Endothelial function; Flow mediated dilation; Platelet activity

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; COLLAGEN; HEMOGLOBIN; PADGEM PROTEIN;

ADULT; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CELL ACTIVITY; CELL SURFACE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFECT; ENDOTHELIAL FUNCTION; ERYTHROCYTE COUNT; FLOW CYTOMETRY; FLOW MEDIATED DILATION; HEART RATE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPEREMIA; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; MALE; NORMAL HUMAN; OPTIMAL DRUG DOSE; PARTIAL THROMBOPLASTIN TIME; PLATELET NEUTROPHIL COMPLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTHROMBIN TIME; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT; VASCULAR ENDOTHELIUM;

ADULT; ANALYSIS OF VARIANCE; ASPIRIN; BLOOD PLATELETS; BRACHIAL ARTERY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; HYPEREMIA; JAPAN; MALE; P-SELECTIN; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; VASODILATION; YOUNG ADULT;

EID: 79959760348     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-010-0054-8     Document Type: Article

References (37)

1. Elwood PC, Cochrane AL, Burr ML, Sweetnam PM, Williams G, Welsby E, Hughes SJ, Renton R (1974) A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J 1:436-440
2. Steering Committee of the Physicians' Health Study Research Group (1989) Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 321:129-135
3. Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, Warlow C, Hafner B, Thompson E, Norton S, Gilliland J, Doll R (1988) Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 296(6618):313-316 (Pubitemid 18042841)
4. Hebert PR, Hennekens CH (2000) An overview of the four randomized trials of aspirin therapy in the primary prevention of vascular disease. Arch Intern Med 160:3123-3127
5. Kubota N, Kasai T, Miyauchi K, Njaman W, Kajimoto K, Akimoto Y, Kojima T, Ken Y, Takeshi K, Hiroyuki D (2008) Therapy with statins and aspirin enhances long-term outcome of percutaneous coronary intervention. Heart Vessels 23:35-39 (Pubitemid 351266887)
6. Antithrombotic Trialists' Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 324:71-86
7. Dyken ML, Barnett HJ, Easton JD, Fields WS, Fuster V, Hachinski V, Norris JW, Sherman DG (1992) Low-dose aspirin and stroke. "It ain't necessarily so". Stroke 23:1395-1399
8. Barnett HJ, Kaste M, Meldrum H, Eliasziw M (1996) Aspirin dose in stroke prevention: beautiful hypotheses slain by ugly facts. Stroke 27:588-592 (Pubitemid 26114414)
9. Taylor DW, Barnett HJ, Haynes RB, Ferguson GG, Sackett DL, Thorpe KE, Simard D, Silver FL, Hachinski V, Clagett GP, Barnes R, Spence JD (1999) Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet 353:2179-2184 (Pubitemid 29295249)
10. Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663-665
11. Willems C, De Groot PG, Pool GA, Gonsalvez MS, Van Aken WG, Van Mourik JA (1982) Arachidonate metabolism in cultured human vascular endothelial cells. Evidence for two prostaglandin synthetic pathways sensitive to acetylsalicylic acid. Biochim Biophys Acta 713:581-588
12. Ozturk O, Greaves M, Templeton A (2002) Aspirin dilemma. Remodelling the hypothesis from a fertility perspective. Hum Reprod 17:1146-1148
13. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R, International Brachial Artery Reactivity Task Force (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257-265
14. Witte DR, Westerink J, de Koning EJ, van der Graaf Y, Grobbee DE, Bots ML (2005) Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? J Am Coll Cardiol 45:1987-1993
15. Dogra G, Rich L, Stanton K, Watts GF (2001) Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria. Diabetologia 44:593-601 (Pubitemid 32411275)
16. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM (2007) Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 115:2390-2397 (Pubitemid 46717961)
17. Mizia-Stec K, Gasior Z, Zahorska-Markiewicz B, Holecki M, Haberka M, Mizia M, Gomułka S, Zak-Gołab A, Gościńska A (2008) The indexes of arterial structure and function in women with simple obesity: a preliminary study. Heart Vessels 23:224-229
18. Fujii N, Tsuchihashi K, Sasao H, Eguchi M, Miurakami H, Hase M, Higashiura K, Yuda S, Hashimoto A, Miura T, Ura N, Shimamoto K (2008) Insulin resistance functionally limits endothelium-dependent coronary vasodilation in nondiabetic patients. Heart Vessels 23:9-15 (Pubitemid 351276810)
19. Crisby M, Kublickiene K, Henareh L, Agewall S (2009) Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease. Heart Vessels 24:90-95
20. Pohl U, Holtz J, Busse R, Bassenge E (1986) Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 8:37-44 (Pubitemid 16161419)
21. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Lüscher TF (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91:1314-1319
22. Husain S, Andrews NP, Mulcahy D, Panza JA, Quyyumi AA (1998) Aspirin improves endothelial dysfunction in atherosclerosis. Circulation 97:716-720 (Pubitemid 28135332)
23. Sun D, Huang A, Smith CJ, Stackpole CJ, Connetta JA, Shesely EG, Koller A, Kaley G (1999) Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice. Circ Res 85:288-293 (Pubitemid 29377301)
24. Taubert D, Berkels R, Grosser N, Schröder H, Gründemann D, Schömig E (2004) Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action. Br J Pharmacol 143:159-165 (Pubitemid 39280035)
25. Born GV (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927-929
26. O'brien JR (1962) Platelet aggregation: Part I some effects of the adenosine phosphates, thrombin, and cocaine upon platelet adhesiveness. J Clin Pathol 15:446-452
27. Peters MJ, Heyderman RS, Hatch DJ, Klein NJ (1997) Investigation of platelet-neutrophil interactions in whole blood by flow cytometry. J Immunol Methods 209:125-135 (Pubitemid 28055702)
28. Yamasaki F, Furuno T, Sato K, Zhang D, Nishinaga M, Sato T, Doi Y, Sugiura T (2005) Association between arterial stiffness and platelet activation. J Hum Hypertens 19:527-533 (Pubitemid 40946037)
29. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE (2005) A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352:1293-1304
30. Gori T, Dragoni S, Lisi M, Di Stolfo G, Sonnati S, Fineschi M, Parker JD (2008) Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function. J Am Coll Cardiol 51:1953-1958 (Pubitemid 351636451)
31. Cahill MR, Newland AC (1993) Platelet activation in coronary artery disease. Br J Biomed Sci 50:221-234 (Pubitemid 23329778)
32. Hung J, Lam JY, Lacoste L, Letchacovski G (1995) Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 92:2432-2436
33. Steinhubl SR, Moliterno DJ (1997) Glycoprotein IIb/IIIa receptor antagonists for the treatment of unstable angina. Heart Vessels Suppl 12:148-155 (Pubitemid 28017757)
34. Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A, PPP Collaborative Group (2003) Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 26:3264-3272 (Pubitemid 37466885)
35. Blann AD, Dobrotova M, Kubisz P, McCollum CN (1995) von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost 74:626-630
36. Davì G, Romano M, Mezzetti A, Procopio A, Iacobelli S, Antidormi T, Bucciarelli T, Alessandrini P, Cuccurullo F, Bittolo Bon G (1998) Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 97:953-957
37. Cannon CP, McLean DS (2006) Critical pathways using platelet testing to potentially optimize the use of oral antiplatelet therapy. Am J Cardiol 98:33N-38N